For research use only. Not for therapeutic Use.
Cofetuzumab (Cat No.: I040373) is an antibody–drug conjugate (ADC) composed of a monoclonal antibody targeting CD70, a protein overexpressed in various cancers, linked to a cytotoxic payload. By binding to CD70 on tumor cells, cofetuzumab delivers the toxin directly into the cancer cell, inducing apoptosis while sparing healthy tissue. It has been investigated for treating malignancies such as renal cell carcinoma and hematologic cancers. Cofetuzumab represents a targeted therapeutic strategy aimed at improving efficacy and reducing systemic toxicity in oncology drug development.
| CAS Number | 1869928-62-0 |
| Purity | ≥95% |
| Reference | [1]. Cofetuzumab. IMGT. |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
